Education
About Us
Working with TipRanks
Follow Us
Steris plc (STE)
NYSE:STE
STE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$200.98 - $252.79
Previous CloseN/A
Volume53.54K
Average Volume (3M)733.82K
Market Cap
$23.96B
Enterprise Value$24.02B
Total Cash (Recent Filing)$171.70M
Total Debt (Recent Filing)$125.00M
Price to Earnings (P/E)39.3
Beta0.55
Next Earnings
Aug 11, 2025EPS Estimate
2.27Next Dividend Ex-Date
Jun 10, 2025Dividend Yield0.92%
Share Statistics
EPS (TTM)2.74
Shares Outstanding98,372,310
10 Day Avg. Volume551,498
30 Day Avg. Volume733,821
Financial Highlights & Ratios
PEG Ratio1.24
Price to Book (P/B)3.64
Price to Sales (P/S)0.00
P/FCF Ratio30.85
Enterprise Value/Market Cap1.00
Enterprise Value/Revenue1.11
Enterprise Value/Gross Profit9.71
Enterprise Value/Ebitda4.53
Forecast
1Y Price Target
$265.83Price Target Upside9.07% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Steris News
Bulls Say, Bears Say
Bulls Say
Investor SentimentInvestor interest in Steris as a 'safe-haven' has risen considerably, highlighting its ability to deliver stable and reliable growth.
Market PositionSTE benefits from its position as the second-largest U.S. platform for EO sterilization, presenting a favorable competitive backdrop.
Revenue GrowthIn FY26, a favorable foreign exchange tailwind is expected to boost revenue growth above consensus estimates.
Bears Say
Financial StabilityEO litigation is a significant factor influencing the company's financial stability.
Healthcare PolicyHealthcare policy changes could disrupt STE's business with potential losses in insurance coverage impacting procedure volumes.
Macro And Political RisksMacro and political uncertainties are expected to slow down revenue growth in FY27 compared to consensus forecasts.
Ownership Overview
0.31% Insiders
27.82% Mutual Funds
26.37% Other Institutional Investors
19.94% Public Companies and Individual Investors
STE FAQ
What was Steris plc’s price range in the past 12 months?
Steris plc lowest stock price was $200.98 and its highest was $252.79 in the past 12 months.
What is Steris plc’s market cap?
Steris plc’s market cap is $23.96B.
When is Steris plc’s upcoming earnings report date?
Steris plc’s upcoming earnings report date is Aug 11, 2025 which is in 65 days.
How were Steris plc’s earnings last quarter?
Steris plc released its earnings results on May 14, 2025. The company reported $2.74 earnings per share for the quarter, beating the consensus estimate of $2.599 by $0.141.
Is Steris plc overvalued?
According to Wall Street analysts Steris plc’s price is currently Undervalued.
Does Steris plc pay dividends?
Steris plc pays a Quarterly dividend of $2.226 which represents an annual dividend yield of 0.92%. See more information on Steris plc dividends here
What is Steris plc’s EPS estimate?
Steris plc’s EPS estimate is 2.27.
How many shares outstanding does Steris plc have?
Steris plc has 98,372,310 shares outstanding.
What happened to Steris plc’s price movement after its last earnings report?
Steris plc reported an EPS of $2.74 in its last earnings report, beating expectations of $2.599. Following the earnings report the stock price went up 8.519%.
Which hedge fund is a major shareholder of Steris plc?
Currently, no hedge funds are holding shares in STE
Steris Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$265.83 (9.07% Upside)
$265.83 (9.07% Upside)
Blogger Sentiment
Bullish
STE Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 165.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $7.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 9.6%
Last 30 Days ▲ 9.6%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.99%
12-Months-Change
Fundamentals
Return on Equity
9.46%
Trailing 12-Months
Asset Growth
-8.29%
Trailing 12-Months
Company Description
Steris plc
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
STE Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong financial performance with significant revenue and earnings growth, record free cash flow, and improved margins in key segments. However, challenges such as a decline in healthcare capital equipment revenue, tariff costs, and legal settlement impacts on cash flow present concerns. Despite these issues, the overall sentiment remains positive due to the outweighing highlights.Read More>STE Revenue Breakdown
73.00% U.S.
25.39% Other locations
1.61% Ireland
STE Stock 12 Month Forecast
Average Price Target
$265.83
▲(9.07%Upside)